Literature DB >> 20335593

Metabolism, gliomas, and IDH1.

Jan Smeitink1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335593     DOI: 10.1056/NEJMcibr0912922

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.

Authors:  Ayelet Erez; Oleg A Shchelochkov; Sharon E Plon; Fernando Scaglia; Brendan Lee
Journal:  Am J Hum Genet       Date:  2011-04-08       Impact factor: 11.025

2.  IDH1 and IDH2 mutations in myeloid neoplasms--novel paradigms and clinical implications.

Authors:  Mario Cazzola
Journal:  Haematologica       Date:  2010-10       Impact factor: 11.047

3.  Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2.

Authors:  D Thirumal Kumar; L Jerushah Emerald; C George Priya Doss; P Sneha; R Siva; W Charles Emmanuel Jebaraj; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2018-07-09       Impact factor: 3.655

4.  The Influence of Methylating Mutations on Acute Myeloid Leukemia: Preliminary Analysis on 56 Patients.

Authors:  Sergiu Pasca; Cristina Turcas; Ancuta Jurj; Patric Teodorescu; Sabina Iluta; Ionut Hotea; Anca Bojan; Cristina Selicean; Bogdan Fetica; Bobe Petrushev; Vlad Moisoiu; Alina-Andreea Zimta; Valentina Sas; Catalin Constantinescu; Mihnea Zdrenghea; Delia Dima; Ciprian Tomuleasa
Journal:  Diagnostics (Basel)       Date:  2020-04-29

5.  Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging.

Authors:  Hye Rim Cho; Bora Hong; Hyeonjin Kim; Chul-Kee Park; Sung-Hye Park; Sunghyouk Park; Seung Hong Choi
Journal:  Oncotarget       Date:  2016-10-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.